CCRM provides innovative​ CDMO services to enable the development and commercialization of cell and gene therapies and regenerative medicine-based technologies. With our customer-focused approach customized to each client, we provide process development and current Good Manufacturing Practices (cGMP) manufacturing services tailored to our clients’ timelines, financing, ambitions and needs.
We offer comprehensive development from the benchtop to commercially-ready manufacturing solutions.

We help move therapies from concept to market

Our team of experts has over 300 combined years of cell and gene therapy experience. Our scientific and engineering expertise and know-how can help emerging and established partners in the regenerative medicine field go from concept to market.

CCRM’s expertise in developing, scaling up and manufacturing cell and gene therapies includes:

  • Process scale-up and scale-out, closure and automation
  • Media formulation and development
  • Gene editing and cell reprogramming
  • Cryopreservation
  • Cell (iPSC, CAR-T, MSC, NK, HEK) and viral vector (LVV, AAV) process development and optimization for commercial manufacturing
  • Analytical assay development
  • cGMP manufacturing of master/working cell banks
  • cGMP manufacturing of cell and gene therapies for Phase I and II clinical trials
We provide consulting services for business planning, market intelligence and regulatory property.
40,000 square ft facility space
World Class Scientific Expertise
In the heart of Toronto's Discovery District

Read about our work below: